Our in vitro coculture system experiments and xenograft animal model revealed that TAM-derived CCL22 directly induced ESCC cell invasion and lymphatic metastasis by inducing EMT and promoting MMP secretion from tumor cells, expanding the tumor-promoting effect of CCL22 on ESCC. This evidence concerns the gene CCL22 and esophageal squamous cell carcinoma.